DelveInsight has launched a new report on Frontotemporal Dementia – Epidemiology Forecast to 2030
DelveInsight’s ‘Frontotemporal Dementia – Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Frontotemporal Dementia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Some of the key facts of the Report:
“According to DelveInsight’s analysis, males are affected more as compared to females, in the case of Frontotemporal Dementia.”
Frontotemporal dementia (FTD) is a hypernym for a diverse group of uncommon disorders that basically affect the frontal and temporal lobes of brain areas. In this disorder, portions of these lobes shrink (atrophy). The degeneration of frontotemporal ear is primarily triggered due to proteins involvement TDP43 and tau, which directly outbreaks the damage on the temporal and frontal lobes of the brain. Signs and symptoms may vary, depending upon the portion of the brain affected. Some people with frontotemporal dementia undergo alot of changes in their personality and become socially inappropriate, impulsive, or emotionally indifferent, while others lose the ability to use language.
In addition to this, based on the distinct patterns of signs and symptoms, three different clinical syndromes have been grouped under the category of “frontotemporal dementia” (FTD):
Frontotemporal dementia is a clinically and pathologically heterogeneous familial and sporadic neurodegenerative disorder usually manifesting, at its onset, as focal disintegration of temperament, judgment, conduct, and speech. It is, along with Alzheimer disease (AD), a leading cause of dementia developing in midlife or earlier. It typically develops in the sixth decade of life. Still, some cases arise in youth where it may mimic psychiatric disorders such as schizophrenia, bipolar affective disorder and major depression and others in later life.
“According to the Association for Frontotemporal Degeneration 2019, FTD represents an estimated 10-20% of all dementia cases. It is recognized as one of the most common presenile dementias.”
Request a Free Sample Report @ https://www.delveinsight.com/sample-request/frontotemporal-dementia-epidemiology-forecast
Scope of the Report
KOL- Views
We interview, KOLs and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.
Request for Sample Pages: https://www.delveinsight.com/sample-request/frontotemporal-dementia-epidemiology-forecast
Key Questions Answered
Reasons to buy
Key Assessments
Related Reports:
Frontotemporal Dementia – Pipeline Insights, 2020
The Frontotemporal Dementia report provides an overview of therapeutic pipeline activity and therapeutic assessment of the products by development stage, product type, route of administration, molecule type, and MOA type for Frontotemporal Dementia across the complete product development cycle, including all clinical and nonclinical stages.
Frontotemporal Dementia – Market Insights, Epidemiology, and Market Forecast-2030
The Frontotemporal Dementia market report provides current treatment practices, emerging drugs, Frontotemporal Dementia market share of the individual therapies, current and forecasted Frontotemporal Dementia market Size from 2017 to 2030 segmented by seven major markets.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Vinita Rakheja Email: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/